These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26891752)

  • 1. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis interfaced with a mass spectrometer (CE-MS): technical considerations and applicability for biomarker studies in animals.
    Albalat A; Husi H; Siwy J; Nally JE; McLauglin M; Eckersall PD; Mullen W
    Curr Protein Pept Sci; 2014 Feb; 15(1):23-35. PubMed ID: 24555889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.
    Stalmach A; Albalat A; Mullen W; Mischak H
    Electrophoresis; 2013 Jun; 34(11):1452-64. PubMed ID: 23512263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
    Zürbig P; Schiffer E; Mischak H
    Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.
    Metzger J; Schanstra JP; Mischak H
    Anal Bioanal Chem; 2009 Mar; 393(5):1431-42. PubMed ID: 18704377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative protein biomarker panels: a path to improved clinical practice through proteomics.
    Hartl J; Kurth F; Kappert K; Horst D; Mülleder M; Hartmann G; Ralser M
    EMBO Mol Med; 2023 Apr; 15(4):e16061. PubMed ID: 36939029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the CE-MS platform as a powerful alternative to conventional couplings in bio-omics and target-based applications.
    Robledo VR; Smyth WF
    Electrophoresis; 2014 Aug; 35(16):2292-308. PubMed ID: 24488766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
    Albalat A; Mischak H; Mullen W
    Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
    Fliser D; Wittke S; Mischak H
    Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted mass spectrometry approaches for protein biomarker verification.
    Meng Z; Veenstra TD
    J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future.
    Latosinska A; Siwy J; Mischak H; Frantzi M
    Electrophoresis; 2019 Sep; 40(18-19):2294-2308. PubMed ID: 31054149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing translational research and precision medicine with targeted proteomics.
    Uzozie AC; Aebersold R
    J Proteomics; 2018 Oct; 189():1-10. PubMed ID: 29476807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.
    Hawkridge AM; Muddiman DC
    Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():265-77. PubMed ID: 20636062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
    Metzger J; Luppa PB; Good DM; Mischak H
    Crit Rev Clin Lab Sci; 2009; 46(3):129-52. PubMed ID: 19404829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods in capillary electrophoresis coupled to mass spectrometry for the identification of clinical proteomic/peptidomic biomarkers in biofluids.
    Stalmach A; Husi H; Mosbahi K; Albalat A; Mullen W; Mischak H
    Methods Mol Biol; 2015; 1243():187-205. PubMed ID: 25384747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CE-MS-based proteomics in biomarker discovery and clinical application.
    Pontillo C; Filip S; Borràs DM; Mullen W; Vlahou A; Mischak H
    Proteomics Clin Appl; 2015 Apr; 9(3-4):322-34. PubMed ID: 25641774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.